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Objective. To determine the serologic specificity 
of acid eluates from tissues of a child who died with 
congenital complete heart block (CCHB). 
Methods. Tissues were extracted, acid eluted, 
and the IgG and antibody titers determined on the 
eluates by enzyme-linked immunosorbent assay. 
Results. Antibodies to native 60-kd and dena- 
tured 52-kd RoISS-A were found to be enriched only in 
the heart eluate, and not in the eluates from brain, 
kidney, and skin. 
Conclusion. These findings indicate a major role 
for anti-native 60-kd RoISS-A in the immunopathogen- 
esis of CCHB. 
Neonatal lupus erythematosus is a disease that 
is characterized frequently by dermatitis and congen- 
ital complete heart block (CCHB), less commonly by 
thrombocytopenia, and rarely by cholestatic hepatitis. 
The disease is usually associated with transplacental 
passage of IgG antibodies to the small ribonucleopro- 
tein particle Ro/SS-A and, slightly less frequently, 
LdSS-B (1-9). Rarely, neonatal lupus dermatitis is 
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associated with antibodies to the ribonucleoprotein 
particle U1 RNP (10). 
While recent studies have attempted to assess risk 
of a mother with systemic lupus erythematosus (SLE) or 
an asymptomatic mother with antibodies to Ro/SS-A 
and/or LdSS-B bearing a child with CCHB, this is at 
best an indirect approach to risk assessment since the 
condition develops in only a small fraction of children 
born to such mothers. Moreover, in the only prospective 
study to date, of 38 children born to SLE mothers with 
anti-Ro and/or anti-La or with anti-RNP/Sm, none had 
CCHB (11). Thus, perhaps only 2-5% of mothers at 
risk for having a child with CCHB actually do so. 
Attention has therefore turned to the study of 
the hearts of children with CCHB who have died of 
cardiac failure. In 3 instances, IgG has been demon- 
strated in the inflammatory deposits in the heart of 
children with CCHB (12-14). In 1 of these cases, IgG 
and IgA globulin were found in a diffuse pattern (12), 
and diffuse cytoplasmic deposits of IgG and IgM were 
described in another (13). The third report described 
particulate deposits of IgG, with no IgM or IgA 
deposition (14). Finally, in a study using anti-LdSS-B 
antiidiotypic serum, the idiotype of an anti-LdSS-B 
antibody was seen on the surface of myocardial fibers 
from a child with CCHB (15). In addition, anti-La/ 
SS-B was demonstrated in both phosphate buffered 
saline (PBS) washes and guanidinium eluates of heart 
sections (15). The methods used in the first studies 
(12-14) do not enable determination of the specificity 
of the Ig deposits and, like the methods in the anti- 
idiotype studies (13, are not quantitative. 
We report the first quantitative elution studies 
of several tissues from a child who died in utero with 
CCHB. The mother had SLE with anti-Ro/SS-A anti- 
bodies but no detectable antibodies to LdSS-B or 
ANTI-60-kd Ro/SS-A IN CCHB 1699 
other RNA proteins such as U1 RNP or Sm. We 
determined both the IgG content and the anti-Ro/SS-A 
activity in the acid eluates of saline-washed homoge- 
nates of various organs, as well as in the mother’s 
serum. This enabled us to compare the antibody 
content per unit weight of IgG in such eluates and to 
compare these values with the antibody content per 
unit weight of IgG in the mother’s serum. The results 
showed that autoantibodies to the native 60-kd Rol 
SS-A molecule were enriched 2.9-fold in the eluate 
from the heart tissue compared with the maternal 
serum, but similarly prepared eluates from the skin, 
kidney, and brain were not enriched for anti-ROBS-A. 
PATIENT AND METHODS 
Description of the mother with SLE and the child with 
CCHB. The patient is a 30-year-old Italian woman. She had 
experienced arthralgias for many years. She gave birth to a 
healthy baby in 1989. In 1991 she presented with adeno- 
pathy, low-grade fever, and a butterfly rash on the face. The 
antinuclear antibody titer was 1: 1,080 with a homogeneous 
pattern as seen on HEp-2 cells. 
The Crirhidia Iuciliae titer was 1:30, indicating sig- 
nificantly positive anti-double-stranded DNA. The anti- 
single-stranded DNA level was 21% (normal <lo%). The 
only precipitin demonstrated was anti-Ro/SS-A, on calf 
thymus extract. 
In 1992, the patient noted alopecia. During that year 
she became pregnant for the second time. At 21 weeks of 
gestation, fetal echocardiography showed a normal fetal 
heart with a ventricular rate of 50-60 beats per minute, while 
the atrial rate was 140-150 beats per minute; fetal signs of 
heart failure were absent. The maternal anti-Ro titer was 
1:128. At 34 weeks of gestation, a few days before the 
scheduled caesarean section, the mother noted decreased 
spontaneous fetal movements. She was seen by an obstetri- 
cian, who performed serial fetal echographies (March 22,24, 
and 25, 1993). On March 25, the fetus was found to be dead. 
The next day, labor was induced, and a girl weighing -2,600 
gm was born. Fetal tissues were frozen immediately, and 
maternal serum was stored. These were shipped on dry ice 
to Oklahoma City, by overnight delivery. 
Preparation of eluates. Tissues were weighed in the 
frozen state on a Mettler PC400 pan balance, to within 0.1 
gm. The samples, which varied in size from 1.1 gm (skin) to 
9.0 gm (heart), were then mixed with 3 volumes of PBS, pH 
7.2, and homogenized with either a hand-held homogenizer 
(skin and kidney) or a small Waring blender (heart and 
brain). The comparable efficiency of the homogenization 
methods was demonstrated by the very similar IgG concen- 
trations and anti-Ro/SS-A titers in the saline extracts. In- 
deed, the anti-Ro/SS-A activity per pg IgG was indistin- 
guishable in the saline extracts for all 4 organs. 
The homogenates were spun for 40 minutes at 900g in 
a refrigerated centrifuge. The supernatants were separated 
(saline extract of tissue), and the pellets were washed 4 times 
in the cold with 3 volumes of PBS and centrifuged. The final 
concentration of IgG in the fourth wash was 50.2 pghl in all 
cases, as determined by a sandwich assay for Ig determina- 
tion (see below). The pellets were then extracted with 0.2M 
glycine buffer, pH 2.4, as described previously (16). The acid 
eluates were dialyzed against 100 volumes of PBS. Precipi- 
tates were removed by centrifugation, and the soluble elu- 
ates were then studied for IgG concentration, antibody to 
bovine Ro/SS-A by enzyme-linked immunosorbent assay 
(ELISA), and antibody to LdSS-B by ELISA. The precip- 
itates were studied by sodium dodecyl sulfate-polyacrylamide 
gel electrophoresis (SDS-PAGE) for the presence of 60-kd and 
52-kd Ro/SS-A as well as for LdSS-B, and none was found. 
Serum samples from the mother were tested for all these 
parameters simultaneously on the same ELISA plates. 
Analytic immunochemical methods. ELISA for anti- 
body to Ro/SS-A and LdSS-B was performed as described 
previously (17). All experiments were performed in dupli- 
cate, and 2 independent preparations beginning with 
weighed tissue were used for each of the various tissue 
sources. Results of the 2 experiments were always indistin- 
guishable. 
Immunofluorescence technique. Four micron-thick 
frozen sections of heart, kidney, and skin were incubated 
with rabbit F(ab’), fluorescein-conjugated anti-human IgG, 
IgM, and IgA (Dako, Carpinteria, CA) at 1:250 dilutions for 
2 hours at room temperature. Mounting medium consisted of 
glycerol-PBS with 0.1% p-phenylenediamine. 
The ELISA for quantitating IgG was carried out by 
a sandwich method. Affinity-purified goat anti-human IgG 
(Sigma, St. Louis, MO) at a concentration of 2 pg/ml in 
O.05M carbonate buffer, pH 9.2, was coated onto polyvinyl 
chloride microtiter plates (Costar, Cambridge, MA). A stan- 
dard curve was constructed with concentrations of Cohn 
fraction I1 from 2.0 pg/ml to 0.02 pg/ml. Dilutions of serum 
and eluates were used to charge plates, which were always 
accompanied by a standard curve. Binding of IgG was 
assessed by development with a goat anti-human IgG ( y  
chain-specific) alkaline phosphatase conjugate (affinity puri- 
fied; Sigma) at a dilution of 15,000, followed by the sub- 
strate NBTIBCIP. Color development was read at 405 nm 
with a Dynatech (Alexandria, VA) scanner. IgG and anti- 
Ro/SS-A ELISAs were always carried out with precisely the 
same diluted samples of serum and eluate on the same plate. 
ELISA for antibodies to recombinant 52-kd RolSS-A. 
An ELISA was developed to detect antibodies that bind to 
the human recombinant 52-kd Ro protein expressed in 
Escherichia coli under the control of the lac promoter. The 
protein was solubilized in 7M urea after lysis of the cells by 
sonication. These proteins were diluted in a carbonate buffer 
(pH 9.6, with 1 mM MgC1,) and used to coat 96-well plates 
(Costar, Cambridge, MA). Optical densities (OD) at 405 nm 
were detected after reaction with an alkaline phosphatase- 
conjugated goat anti-human IgG (Sigma) and 1 mg/ml p -  
nitrophenyl phosphate. These values were corrected by 
subtracting optical densities obtained from similarly treated 
extracts from E coli that contained the expression vector but 
lacked the human 52-kd Ro complementary DNA insert. 
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Table 1. Yield of acid-eluted IgG from various organs of the 
stillborn child with congenital comDlete heart block 
Eluted IgG, 
Organ &gm tissue 
Heart 
Skin 
Kidney 
Brain 
15.7 
3.7 
4.0 
3.0 
RESULTS 
Quantitation of eluate immunoglobulin from the 
various organs is listed in Table 1. It is noteworthy that 
the heart yielded, on average, -4 times as much IgG in 
the neutralized acid eluates as did skin, kidney, or 
brain. In parallel with this finding, the only eluate 
whose specific activity differed from that of the mater- 
nal serum (OD in anti-Ro/SS-A ELISNmg IgG) was 
the heart eluate (Figure 1). 
As seen in Figure 1, the curve for the heart 
eluate was displaced to the left, meaning that this IgG 
was more active as anti-Ro on a weight basis, com- 
pared with maternal serum IgG or the eluates from the 
other tissues. By comparing the quantities of IgG 
required to achieve the same OD along the curves of 
the serum and the heart eluate, the ratio of serum IgG: 
eluate IgG was calculated to be 2.9. This can be 
considered to be an enrichment ratio, meaning that 
eluate IgG was 2.9 times more effective than serum 
IgG in anti-Ro/SS-A activity. This is taken as evidence 
I 
I I I 1 I 
0.2 0.4 0.6 0.8 1.0 
pg IgG/ml 
Figure 1. Results of enzyme-linked immunosorbent assay on poly- 
vinyl chloride microtiter plates coated with bovine native 60-kd 
Ro/SS-A and then tested with serum from the patient (0) and eluates 
from various tissues, including heart (O), brain (A), kidney (A), and 
skin (D), from her stillborn child with congenital complete heart 
block. O.D.,, = optical density at 405 nm. 
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Figure 2. Results of enzyme-linked immunosorbent assay on poly- 
vinyl chloride microtiter plates coated with recombinant 52-kd 
Ro/SS-A and then tested with serum from the patient (0) and heart 
eluate from her stillborn child with congenital complete heart block 
(0). O.D., = optical density at 405 nm. 
for specific deposition of autoantibody to the ROBS-A 
antigen in the heart. As seen, the only curves dis- 
placed from the serum were those for the heart eluate 
and the skin eluate. In contrast to the heart eluate, 
which showed enrichment of anti-Ro/SS-A activity, 
the skin eluate curve was displaced slightly to the 
right, suggesting a loss of specific activity. This differ- 
ence could also be nonsignificant. 
Figure 2 shows the curves generated with the 
heart eluate and the maternal serum in an ELISA that 
was specific for antibody to recombinant 52-kd Ro/ 
SS-A. As seen, the curve for the heart eluate was 
displaced to the left of the serum curve, and the 
enrichment ratio (pg serum 1gG:eluate IgG, which 
gave identical OD in ELISA) was 2.6, very similar to 
that achieved in the anti-60-kd Ro/SS-A ELISA. 
In this assay, 125-144 times more IgG was 
required to achieve the same OD in the anti-52-kd 
ROES-A ELISA as in the anti-60-kd ROBS-A ELISA. 
This is consistent with the recent findings that antibod- 
ies to the denatured form of 52-kd Ro/SS-A (measured 
with recombinant 52-kd ROES-A or Western blot) are 
a subset of antibodies to native 60-kd ROBS-A that 
cross-react with 52-kd Ro/SS-A (18). If findings in the 
assays were linear reflections of the antibody concen- 
trations, then the anti-52-kd ROBS-A antibody re- 
sponse would be -0.75% of the anti-60-kd ROBS-A 
response. Whether the anti-52-kd RolSS-A response is 
1% or 10% of the anti-60-kd ROBS-A response, the 
fact that the enrichment ratio for the antibody to the 
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52-kd Ro/SS-A protein in the eluate (2.6) was very 
similar to that for the anti-60-kd RoiSS-A in the eluate 
(2.9) is evidence that there was no further enrichment 
of the antibody to the 52-kd Ro/SS-A. Thus, the major 
antibody (290%) to ROBS-A concentrated in the heart 
is that reactive with the native 60-kd ROES-A antigen. 
Because the serum was so much less active in 
response to the recombinant 52-kd ROBS-A compared 
with the native 60-kd ROES-A, only the serum and the 
heart eluate had measurable activity. No antibody 
response to the recombinant 52-kd ROBS-A was dem- 
onstrated in the skin, kidney, or brain eluates. This 
was not surprising since there was no enrichment for 
anti-60-kd ROBS-A in any of these eluates and the 
yield of IgG in these cases was -25% of that found in 
the heart eluate (see Table 1). 
Finally, to ensure the specificity of the heart 
eluate, the tissue pellet was washed not only 4 times, 
but, in a second experiment, 7 times before acid 
elution. While the yield of IgG eluted from the heart 
dropped by 60%, the specific activity of the eluate 
after 7 washings was identical to that of the eluate 
recovered after 4 saline washings (enriched 2.9-fold), 
as seen in Figure 3. Studies of the IgG content of the 
washings showed that for the heart, after 3 washings, 
all subsequent washings had 0.2 pg IgG/ml, which was 
-1% of the content of the first wash. Similar results 
were achieved with the other organs studied. 
Finally, immunofluorescence studies were car- 
ried out on cryostat sections of heart, kidney, and 
skin. The heart, kidney, and skin had deposits of IgG, 
but not IgM or IgA. The IgG deposits were present in 
all sections of tissue examined and appeared to spare 
the cell nuclei. In the kidney and skin, the IgG was 
present in a fine particulate pattern. In the heart, the 
IgG deposits appeared as larger globules, in compari- 
son with the deposits in kidney and skin. 
DISCUSSION 
In these studies, the specific immunologic ac- 
tivity for antibodies to Ro/SS-A antigen in neutralized 
acid eluates of tissues from a child who died with 
CCHB was determined quantitatively. The specific 
enrichment of antibodies to the native 60-kd ROES-A 
antigen in the neutralized eluates of the heart but not 
the skin, kidney, or brain provides evidence for the 
specific deposition of antibodies to the native 60-kd 
Ro/SS-A molecule. Antibodies to the LdSS-B antigen 
were undetectable in studies of the serum and eluates, 
and autoantibodies to the recombinant 52-kd RoISS-A 
1.0 
0.8 
OD. 
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0.2 
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Figure 3. Comparison of results of enzyme-linked immunosorbent 
assays for antibody to native 60-kd ROES-A in serum from the 
patient (O), heart eluate 1 from her stillborn child with congenital 
complete heart block, which was acid eluted after 4 saline washes 
(O), heart eluate 2 from the child, which was acid eluted after 7 
saline washes (A). O.D.,, = optical density at 405 nm. 
antigen, which were enriched similarly to the anti- 
60-kd ROBS-A response, were 51% of the antibody in 
both the serum and the eluate. No studies of antibody 
response to the native 52-kd RolSS-A antigen were 
performed, since it has been shown in 17 of 17 previ- 
ously studied anti-ROBS-A-positive sera that all of 
the antibody response to the 52-kd Ro/SS-A antigen is 
to the denatured form measurable in a recombinant 
ELISA (19), as was done here. 
Such studies rest on the assumption that acid 
elution of saline-washed homogenates releases specific 
immune complexes from tissues. After neutralization, 
any antigen not destroyed by acid would reprecipitate 
some of the extracted specific antibody, and indeed, 
precipitates regularly formed after neutralization in 
these studies. Redissolving such precipitates in the 
SDS-2-mercaptoethanol buffer used in SDS-PAGE 
failed to reveal ROBS-A antigen when such gels were 
probed with appropriate sera. We have no simple way 
to quantitate “anti-Ro/SS-A” in such precipitates, 
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and so we measured the free anti-Ro/SS-A remaining 
in acid eluates after neutralization, probably repre- 
senting only a fraction of the immune complexes 
actually deposited in the tissue. However, this 
method, pioneered by investigators at Rockefeller 
University (20) in the study of acid eluates from the 
kidneys of patients with lupus nephritis, has been 
applied to studies of anti-RolSS-A in the kidneys of 
such patients (16) and from the salivary glands of a 
patient with Sjogren’s syndrome (21). These studies all 
provided strong evidence for deposition of specific 
antibodies in damaged organs and have been central in 
the formulation of concepts of immunopathogenesis in 
these disorders. 
This is the first application of such methods to 
the heart disease of neonatal lupus and provides strong 
evidence, in a single case, for the involvement of 
antibodies to the native 60-kd Ro/SS-A antigen in the 
immunopathogenesis of CCHB. These studies do not 
rule out the involvement of antibodies to LdSS-B 
andlor the 52-kd ROBS-A in other cases of CCHB. 
Anti-LdSS-B and antibodies to the 52-kd ROES-A in 
maternal serum conferred a high risk for CCHB in one 
study (22), but in another study, no evidence was 
found for a unique heart block-associated anti-Ro/ 
SS-A autoantibody profile (23). Moreover, in our 
studies using gel diffusion, ELISA, and Western blot, 
while all mothers of children with CCHB (1 1 of 1 1) had 
anti-native 60-kd ROBS-A, only 4 of 11 CCHB sera 
tested had anti-LdSS-B by gel diffusion or immuno- 
blotting (24). There may also be other, as-yet- 
unrecognized, antigen-antibody systems involved in 
the pathogenesis of this and other cases of neonatal 
lupus. These studies show that at least one antibody 
known to be present in the vast majority of mothers, if 
not all mothers, bearing children with CCHB can 
specifically concentrate in the heart of the child. 
These studies do not answer the question of 
why CCHB occurs in only a small number of children 
born to mothers who have anti-Ro/SS-A in their sera, 
or why adults who carry anti-Ro/SS-A in their sera are 
so rarely found to have heart block. However, the 
existence of several fraternal twin pairs discordant for 
CCHB indicates the presence of an as-yet-unidentified 
crucial factor in the child (11,25,26). The existence of 
identical HLA genes in the discordant twin pair for 
CCHB reported from our laboratory (26) indicates that 
the factor in the child, if genetic, is not located in the 
major histocompatibility complex region of chromo- 
some 6. Finally, it is well known that the dermatitis 
and CCHB tend to occur independently in neonatal 
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lupus erythematosus, making it likely that there are 
distinctive and independent determinants for these 2 
clinical manifestations. Quantitative elution studies of 
larger numbers of tissues from children who die of 
CCHB-related heart disease should shed further light 
on this disorder. 
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